Partner Investment Management, L.P. 13F annual report

Partner Investment Management, L.P. is an investment fund managing more than $13.9 million ran by Darin Sadow. There are currently 41 companies in Mrs. Sadow’s portfolio. The largest investments include Audentes Therapeutics Inc and Alexion Pharmaceuticals, together worth $1.98 million.

Limited to 30 biggest holdings

$13.9 million Assets Under Management (AUM)

As of 7th October 2020, Partner Investment Management, L.P.’s top holding is 17,795 shares of Audentes Therapeutics Inc currently worth over $1.07 million and making up 7.6% of the portfolio value. In addition, the fund holds 8,421 shares of Alexion Pharmaceuticals worth $911 thousand, whose value grew 24.5% in the past six months. The third-largest holding is Allena Pharmaceuticals worth $776 thousand and the next is Gilead Sciences worth $708 thousand, with 10,898 shares owned.

Currently, Partner Investment Management, L.P.'s portfolio is worth at least $13.9 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Partner Investment Management, L.P.

The Partner Investment Management, L.P. office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, Darin Sadow serves as the General Counsel and Chief Compliance Officer at Partner Investment Management, L.P..

Recent trades

In the most recent 13F filing, Partner Investment Management, L.P. revealed that it had opened a new position in Biogen and bought 1,839 shares worth $546 thousand. This means they effectively own approximately 0.1% of the company. Biogen makes up 5.2% of the fund's Health Care sector allocation and has grown its share price by 29.1% in the past year.

The investment fund also strengthened its position in Aerie Pharmaceuticals by buying 1,304 additional shares. This makes their stake in Aerie Pharmaceuticals total 18,035 shares worth $436 thousand. Aerie Pharmaceuticals dropped 41.2% in the past year.

On the other hand, there are companies that Partner Investment Management, L.P. is getting rid of from its portfolio. Partner Investment Management, L.P. closed its position in Novo-nordisk A S on 14th February 2020. It sold the previously owned 17,526 shares for $6.17 million. Darin Sadow also disclosed a decreased stake in Audentes Therapeutics Inc by 0.3%. This leaves the value of the investment at $1.07 million and 17,795 shares.

One of the smallest hedge funds

The two most similar investment funds to Partner Investment Management, L.P. are Context Capital Management and Cpv Partners. They manage $13.9 million and $13.8 million respectively.

Darin Sadow investment strategy

Partner Investment Management, L.P.’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 76.0% of the total portfolio value. The fund focuses on investments in the United States as 70.7% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 46% of the total holdings value. On the other hand, small-cap stocks make up only 7.3% of the portfolio. The average market cap of the portfolio companies is close to $38.7 billion.

The complete list of Partner Investment Management, L.P. trades based on 13F SEC filings

These positions were updated on February 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Novo-nordisk A S	Closed 17,526	$6,172,000
Nxp Semiconductors N V	Closed 20,473	$2,234,000
Microchip Technology, Inc.	Closed 23,996	$2,229,000
Twilio, Inc.	Closed 15,783	$1,735,000
Western Digital Corp.	Closed 26,326	$1,570,000
Intuit, Inc.	Closed 5,722	$1,522,000
salesforce.com, inc.	Closed 10,032	$1,489,000
GoDaddy, Inc.	Closed 21,910	$1,446,000
Wellcare Health Plans Inc	Closed 4,757	$1,233,000
Audentes Therapeutics Inc	29.86% 17,795	$1,065,000	7.65%
Microsoft Corp.	Closed 7,383	$1,026,000
Alexion Pharmaceuticals, Inc.	61.96% 8,421	$911,000	6.54%
Stryker Corp.	Closed 3,728	$806,000
Mks Instrument Inc	Closed 8,701	$803,000
DexCom, Inc.	Closed 5,323	$794,000
Allena Pharmaceuticals, Inc.	No change 284,285	$776,000	5.57%
MyoKardia, Inc.	Closed 14,720	$768,000
Visa, Inc.	Closed 4,427	$761,000
Advanced Micro Devices, Inc.	Closed 25,859	$750,000
Gilead Sciences, Inc.	61.76% 10,898	$708,000	5.08%
PTC Therapeutics, Inc.	Closed 20,028	$677,000
Twitter, Inc.	Closed 15,797	$651,000
Coupa Software, Inc.	Closed 4,773	$618,000
Penumbra, Inc.	70.54% 3,699	$608,000	4.37%
SAGE Therapeutics, Inc.	Closed 4,267	$599,000
uniQure NV	Closed 14,711	$579,000
Zimmer Biomet Holdings, Inc.	79.14% 3,689	$552,000	3.96%
Biogen, Inc.	Opened 1,839	$546,000	3.92%
Nevro Corp.	21.71% 4,515	$531,000	3.81%
Anthem Inc	Opened 1,669	$504,000	3.62%
Humana, Inc.	Opened 1,347	$494,000	3.55%
Cigna Corp.	68.93% 2,216	$453,000	3.25%
IQVIA Holdings, Inc.	65.85% 2,926	$452,000	3.25%
BioMarin Pharmaceutical, Inc.	81.84% 5,329	$451,000	3.24%
Allergan Plc	69.05% 2,282	$436,000	3.13%
Aerie Pharmaceuticals, Inc.	7.79% 18,035	$436,000	3.13%
Live Nation Entertainment In	Closed 6,525	$433,000
Arena Pharmaceuticals, Inc.	67.16% 9,484	$431,000	3.09%
Centene Corp.	Opened 6,838	$430,000	3.09%
Alibaba Group Hldg Ltd	Closed 2,532	$423,000
Mirati Therapeutics, Inc.	Closed 5,370	$418,000
Visteon Corp.	Closed 4,944	$408,000
Novartis A G	60.13% 4,270	$392,000	2.81%
Puma Biotechnology, Inc.	Closed 33,866	$365,000
HCA Healthcare, Inc.	68.87% 2,335	$345,000	2.48%
The Goldman Sachs Group, Inc.	Closed 1,562	$324,000
Pfizer Inc.	Opened 7,492	$294,000	2.11%
Icu Med Inc	Opened 1,381	$258,000	1.85%
Dermira Inc	43.69% 16,892	$256,000	1.84%
ICON plc	56.35% 1,402	$241,000	1.73%
UnitedHealth Group, Inc.	Opened 791	$233,000	1.67%
iRhythm Technologies, Inc.	73.44% 3,389	$231,000	1.66%
Immunomedics, Inc.	Opened 10,880	$230,000	1.65%
Abbott Labs	Opened 2,565	$223,000	1.60%
Inspire Med Sys Inc	Closed 3,549	$217,000
Voyager Therapeutics, Inc.	Closed 11,378	$196,000
Delphi Technologies Plc	Closed 14,179	$190,000
Molina Healthcare, Inc.	80.69% 1,387	$188,000	1.35%
Edwards Lifesciences Corp.	78.81% 788	$184,000	1.32%
Fate Therapeutics, Inc.	Closed 8,899	$138,000
Fluidigm Corp.	7.08% 37,856	$132,000	0.95%
Catalent, Inc.	83.55% 2,231	$126,000	0.90%
MorphoSys AG	Opened 994	$126,000	0.90%
AbbVie, Inc.	Opened 1,269	$112,000	0.80%
Axonics Modulation Tech Inc	105.37% 3,978	$110,000	0.79%
Cardiovascular Sys Inc Del	66.44% 1,985	$96,000	0.69%
Vertex Pharmaceuticals, Inc.	Opened 434	$95,000	0.68%
Halozyme Therapeutics, Inc.	Opened 4,650	$82,000	0.59%
Amarin Corp. Plc	Opened 3,757	$81,000	0.58%
Tradeweb Mkts Inc	Closed 2,132	$79,000
Coherus BioSciences, Inc.	51.69% 3,771	$68,000	0.49%
Avrobio, Inc.	Closed 4,669	$66,000
Acorda Therapeutics, Inc.	7.73% 18,342	$37,000	0.27%
Assetmark Finl Hldgs Inc	Closed 961	$25,000
Livongo Health, Inc.	Closed 1,444	$25,000
Eidos Therapeutics, Inc.	Closed 607	$22,000
Equillium, Inc.	Closed 5,333	$20,000
Endologix, Inc.	15.34% 2,440	$4,000	0.03%
No transactions found
Showing first 500 out of 78 holdings